ResVita Bio adds dermatologist John Doux to board of directors Jun 9, 2026 08:43AM
Form 13F-HR Palo Alto Investors LP For: Mar 31 May 15, 2026 04:30PM
Evernorth names new board members ahead of planned public listing May 5, 2026 08:01AM
Palvella appoints dermatologist John Doux to board of directors Apr 13, 2026 07:30AM
First Tracks Biotherapeutics secures $145 million private placement ahead of spinoff Mar 27, 2026 09:00AM
View Older Stories

Mar 27, 2026 09:00AM AnaptysBio board approves First Tracks Biotherapeutics spin-off
Feb 17, 2026 04:39PM Form 13F-HR Palo Alto Investors LP For: Dec 31
Feb 17, 2026 04:35PM Form SCHEDULE 13G eHealth, Inc. Filed by: Palo Alto Investors LP
Nov 14, 2025 04:25PM Form 13F-HR Palo Alto Investors LP For: Sep 30
Sep 17, 2025 01:02AM Oruka Therapeutics raises $180 million in private placement
Aug 22, 2025 06:01AM Form N-PX Palo Alto Investors LP For: Jun 30
Aug 14, 2025 05:15PM Form 13F-HR Palo Alto Investors LP For: Jun 30
May 15, 2025 04:39PM Form 13F-HR Palo Alto Investors LP For: Mar 31
Feb 14, 2025 04:19PM Form 13F-HR Palo Alto Investors LP For: Dec 31
Feb 13, 2025 04:03PM Form SCHEDULE 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP
Nov 14, 2024 04:11PM Form 13F-HR Palo Alto Investors LP For: Sep 30
Aug 29, 2024 06:14AM Form N-PX Palo Alto Investors LP For: Jun 30
Aug 14, 2024 04:19PM Form 13F-HR Palo Alto Investors LP For: Jun 30
May 15, 2024 04:14PM Form 13F-HR Palo Alto Investors LP For: Mar 31
Apr 30, 2024 09:00AM Kamari Pharma Appoints Dr. John Doux to its Board of Directors
Feb 15, 2024 02:35PM Form 13F-HR/A Palo Alto Investors LP For: Dec 31
Feb 14, 2024 04:56PM Form SC 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP
Feb 14, 2024 04:55PM Form SC 13G/A eHealth, Inc. Filed by: Palo Alto Investors LP
Feb 14, 2024 04:52PM Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors LP
Feb 14, 2024 04:15PM Form 13F-HR Palo Alto Investors LP For: Dec 31
Nov 14, 2023 08:40PM Form 13F-HR Palo Alto Investors LP For: Sep 30
Oct 30, 2023 07:05AM VYNE Therapeutics (VYNE) Announces Private Placement of $88 Million
Oct 30, 2023 07:05AM VYNE Therapeutics Announces Private Placement of $88 Million
Aug 14, 2023 04:25PM Form 13F-HR Palo Alto Investors LP For: Jun 30
Jul 20, 2023 07:58AM Gossamer Bio Inc. (GOSS) Announces $212M Private Placement Financing
Jul 20, 2023 07:56AM Gossamer Bio Announces $212 Million Private Placement Financing
May 15, 2023 05:07PM Form 13F-HR Palo Alto Investors LP For: Mar 31
Apr 3, 2023 02:24PM Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors LP
Mar 28, 2023 05:14PM Form 4 ALIMERA SCIENCES INC For: Mar 24 Filed by: Palo Alto Investors LP
Feb 14, 2023 04:44PM Form 13F-HR Palo Alto Investors LP For: Dec 31
Feb 14, 2023 04:44PM Form SC 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP
Feb 14, 2023 04:39PM Form SC 13G/A eHealth, Inc. Filed by: Palo Alto Investors LP
Feb 14, 2023 04:29PM Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors LP
Feb 14, 2023 04:27PM Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors LP
Feb 14, 2023 04:24PM Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors LP
Feb 14, 2023 04:23PM Form SC 13G/A Epizyme, Inc. Filed by: Palo Alto Investors LP
Feb 14, 2023 04:17PM Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors LP
Jan 5, 2023 07:00AM ACELYRIN, INC. Furthers Leadership Position in Immunology with Transformative Acquisition of ValenzaBio
Nov 14, 2022 04:30PM Form 13F-HR Palo Alto Investors LP For: Sep 30
Aug 15, 2022 05:31PM Form 13F-HR Palo Alto Investors LP For: Jun 30
May 16, 2022 04:54PM Form 13F-HR Palo Alto Investors LP For: Mar 31
Apr 28, 2022 04:34PM Peak Bio to Go Public Via Merger with Ignyte Acquisition Corp (IGNY) in $278M Deal
Apr 28, 2022 04:32PM Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
Feb 14, 2022 06:25PM Form SC 13G/A Epizyme, Inc. Filed by: Palo Alto Investors LP
Feb 14, 2022 06:19PM Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors LP
Feb 14, 2022 06:19PM Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors LP
Feb 14, 2022 05:39PM Form SC 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP
Feb 14, 2022 05:36PM Form SC 13G/A eHealth, Inc. Filed by: Palo Alto Investors LP
Feb 14, 2022 05:28PM Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors LP
Feb 14, 2022 05:28PM Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors LP
View Older Stories